---
category: news
title: "Genesis Therapeutics Rakes In $200M For AI-Powered Drug Discovery"
excerpt: "The startup’s physics-centric AI platform is what sets it apart from its competitors, Sklaroff argued. Genesis has “deep expertise” in physics-based methods for computational chemistry, which the company combines with its proprietary machine learning ..."
publishedDateTime: 2023-08-22T00:11:00Z
originalUrl: "https://medcitynews.com/2023/08/biotech-ai-physics-drug-discovery-venture-capital/"
webUrl: "https://medcitynews.com/2023/08/biotech-ai-physics-drug-discovery-venture-capital/"
type: article
quality: 37
heat: -1
published: false

provider:
  name: MedCity News
  domain: medcitynews.com

topics:
  - AI

images:
  - url: "https://medcitynews.com/uploads/2017/01/GettyImages-488634096.jpg"
    width: 683
    height: 512
    isCached: true

related:
  - title: "Genesis raises $200m for AI drug discovery engine"
    excerpt: "The latest round takes the total raised by Burlingame, California-based Genesis to $280 million and will be used to transition to a clinical-stage drug developer, according to the company. Its first round brought in $52 million in 2020."
    publishedDateTime: 2023-08-21T21:19:00Z
    webUrl: "https://pharmaphorum.com/news/genesis-raises-200m-ai-drug-discovery-engine"
    type: article
    provider:
      name: pharmaphorum
      domain: pharmaphorum.com
    quality: 39
    images:
      - url: "https://pharmaphorum.com/sites/default/files/2023-08/DNA_molecules_internal_organs.jpg"
        width: 900
        height: 600
        isCached: true
  - title: "Lex Lands $2.75M For AI Writing Tools"
    excerpt: "Los Angeles-based Lex, a startup developing AI-powered writing tools, announced this morning that it has raised $2.75M in a seed funding round. The funding was led by True Ventures. According to the company,"
    publishedDateTime: 2023-08-23T18:06:00Z
    webUrl: "https://www.socaltech.com/lex_lands___7_m_for_ai_writing_tools/s-0083597.html"
    type: article
    provider:
      name: Incubators
      domain: socaltech.com
    quality: 17
  - title: "AI drug discovery company Genesis Therapeutics scores $200 million in new funding"
    excerpt: "A Stanford University spinout, promising a new era of AI-guided drug discovery ... Genesis has no clinical data – in fact, it’s not officially saying yet when it will even start clinical trials, let alone which conditions it is targeting – but ..."
    publishedDateTime: 2023-08-22T15:21:00Z
    webUrl: "https://www.bizjournals.com/sanfrancisco/news/2023/08/22/genesis-therapeutics-200-million-funding.html"
    type: article
    provider:
      name: The Business Journals
      domain: bizjournals.com
    quality: 12

secured: "Nn3zXplw+QAUW3k1uwWn+PDa9M5najXuCUYUxbBCB0d06lm2nFSKlaGZZLTBLMfnPpg3d4YmzZ/FAFblcMLyZzN9TYOQY9a0l1MVfO/GG4n/dxjhoDYOfOP1MPezA8cmAmS+fCNwCjmRgIuCmF7S/IzhnPdJrSovC0i4ZYbeEjbVFw4wlLbP0PeDwwHIa2x5RLsTY71oUBdPljeXscB1KDbISqMpqoCmj8rItrd417irNpr04BJqJO413YOVJXpVl0hMCmJnxEoEmbzt+evEa3HK+SQ7wNz9jO/sEflrl6RSK5iDQjVV5EQ73vtxxWgSCSN9lu055EJMNnDuaslXS/IRpBFLeHU0ov7kWhuYDGo=;jWF6LTrxsrWE2rnyi2gIvA=="
---

